Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1200


Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer.

Zheng CC, Hu HF, Hong P, Zhang QH, Xu WW, He QY, Li B.

Am J Cancer Res. 2019 Jan 1;9(1):186-197. eCollection 2019. Review.


An essential role of PRMT1-mediated EGFR methylation in EGFR activation by ribonuclease 5.

Wang WJ, Hsu JM, Wang YN, Lee HH, Yamaguchi H, Liao HW, Hung MC.

Am J Cancer Res. 2019 Jan 1;9(1):180-185. eCollection 2019.


Neural correlates of chemotherapy-induced emotion regulation impairment in breast cancer patients.

Gan C, Lv Y, Zhao J, Chao HH, Li CR, Zhang C, Yu F, Cheng H.

Am J Cancer Res. 2019 Jan 1;9(1):171-179. eCollection 2019.


Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer.

Sun B, Jensen NR, Chung D, Yang M, LaRue AC, Cheung HW, Wang Q.

Am J Cancer Res. 2019 Jan 1;9(1):145-159. eCollection 2019.


Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features.

Hu M, Guo W, Liao Y, Xu D, Sun B, Song H, Wang T, Kuang Y, Jing B, Li K, Ling J, Yao F, Deng J.

Am J Cancer Res. 2019 Jan 1;9(1):134-144. eCollection 2019.


Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma.

Chen F, Li Y, Li M, Wang L.

Am J Cancer Res. 2019 Jan 1;9(1):108-121. eCollection 2019.


Functional impairment of the HIPK2 small ubiquitin-like modifier (SUMO)-interacting motif in acute myeloid leukemia.

Sung KS, Kim SJ, Cho SW, Park YJ, Tae K, Choi CY.

Am J Cancer Res. 2019 Jan 1;9(1):94-107. eCollection 2019.


A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway.

Zhong B, Shingyoji M, Hanazono M, Nguyễn TTT, Morinaga T, Tada Y, Hiroshima K, Shimada H, Tagawa M.

Am J Cancer Res. 2019 Jan 1;9(1):79-93. eCollection 2019.


A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.

You F, Wang Y, Jiang L, Zhu X, Chen D, Yuan L, An G, Meng H, Yang L.

Am J Cancer Res. 2019 Jan 1;9(1):64-78. eCollection 2019.


Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models.

Ehlerding EB, Lee HJ, Jiang D, Ferreira CA, Zahm CD, Huang P, Engle JW, McNeel DG, Cai W.

Am J Cancer Res. 2019 Jan 1;9(1):53-63. eCollection 2019.


Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.

Bian ZQ, Luo Y, Guo F, Huang YZ, Zhong M, Cao H.

Am J Cancer Res. 2019 Jan 1;9(1):22-35. eCollection 2019.


Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche.

Chen SH, Zhang BY, Zhou B, Zhu CZ, Sun LQ, Feng YJ.

Am J Cancer Res. 2019 Jan 1;9(1):1-21. eCollection 2019. Review.


Erratum: Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC.

Lin S, Wang J, Wang L, Wen J, Guo Y, Qiao W, Zhou J, Xu G, Zhi F.

Am J Cancer Res. 2018 Dec 1;8(12):2590. eCollection 2018.


Incense burning smoke sensitizes lung cancer cells to EGFR TKI by inducing AREG expression.

Tu CY, Wang BW, Cheng FJ, Chen CH, Hsia TC, Wei YL, Chen CY, Hsieh IS, Yeh YL, Wang LY, Chen CM, Chang WC, Huang WC.

Am J Cancer Res. 2018 Dec 1;8(12):2575-2589. eCollection 2018.


miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.

Wang Y, Qin H.

Am J Cancer Res. 2018 Dec 1;8(12):2564-2574. eCollection 2018.


Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinoma.

Chen YL, Hu CM, Hsu JT, Chang CC, Huang TY, Chiang PH, Chen WY, Chang YT, Chang MC, Tien YW, Lee EY, Jeng YM, Lee WH.

Am J Cancer Res. 2018 Dec 1;8(12):2548-2563. eCollection 2018.


Local and systemic Curcumin C3 complex inhibits 4NQO-induced oral tumorigenesis via modulating FGF-2/FGFR-2 activation.

Khandelwal AR, Moore-Medlin T, Ekshyyan O, Gu X, Abreo F, Nathan CO.

Am J Cancer Res. 2018 Dec 1;8(12):2538-2547. eCollection 2018.

Supplemental Content

Loading ...
Support Center